Picture of Oncimmune Holdings logo

ONC Oncimmune Holdings Balance Sheet

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Oncimmune Holdings, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.

2019
May 31st
2020
May 31st
2021
May 31st
2022
May 31st
2023
August 31st
Period Length:
Source:ARSARSARSPRESSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments5.364.248.632.533.21
Net Total Accounts Receivable
Net Total Receivables0.3251.796.857.032.12
Total Inventory
Prepaid Expenses
Total Current Assets66.2316.19.975.57
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.4221.371.591.540.591
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets9.4310.324.317.38.44
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.063.479.7715.11.42
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities1.5710.519.1207.78
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity7.87-0.1945.23-2.730.657
Total Liabilities & Shareholders' Equity9.4310.324.317.38.44
Total Common Shares Outstanding